| __timestamp | United Therapeutics Corporation | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 125883000 | 60987000 |
| Thursday, January 1, 2015 | 69036000 | 125542000 |
| Friday, January 1, 2016 | 72700000 | 210460000 |
| Sunday, January 1, 2017 | 105700000 | 275119000 |
| Monday, January 1, 2018 | 198700000 | 409539000 |
| Tuesday, January 1, 2019 | 117600000 | 547758000 |
| Wednesday, January 1, 2020 | 108100000 | 736300000 |
| Friday, January 1, 2021 | 122500000 | 904200000 |
| Saturday, January 1, 2022 | 146700000 | 1080300000 |
| Sunday, January 1, 2023 | 257500000 | 1262200000 |
| Monday, January 1, 2024 | 1530500000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. From 2014 to 2023, Vertex Pharmaceuticals Incorporated and United Therapeutics Corporation have shown distinct trends in their cost of revenue. Vertex Pharmaceuticals has seen a staggering increase of over 1,900% in its cost of revenue, peaking at approximately $1.26 billion in 2023. This reflects their aggressive expansion and investment in innovative treatments. In contrast, United Therapeutics experienced a more modest growth of around 105%, reaching $257 million in 2023. This steady rise indicates a more conservative approach, focusing on sustainable growth. These trends highlight the strategic differences between the two companies, offering insights into their operational priorities and market positioning. As the pharmaceutical landscape continues to shift, these cost dynamics will play a pivotal role in shaping future strategies.
Cost of Revenue Comparison: AbbVie Inc. vs United Therapeutics Corporation
Analyzing Cost of Revenue: Novartis AG and United Therapeutics Corporation
Cost of Revenue Trends: Pfizer Inc. vs United Therapeutics Corporation
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Teva Pharmaceutical Industries Limited vs United Therapeutics Corporation: Efficiency in Cost of Revenue Explored
United Therapeutics Corporation vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
United Therapeutics Corporation vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for United Therapeutics Corporation and BioCryst Pharmaceuticals, Inc.